Pharmaceutical product placement: Simply script or prescription for trouble?

Journal of Public Policy and Marketing

Volumn 27, Issue 1, 2008, Pages 98-106

  Ta, Sony ^a   Frosch, Dominick L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug advertising; Pharmaceuticals; Product placement

Indexed keywords

EID: 45449102725     PISSN: 07439156     EISSN: 15477207     Source Type: Journal    
DOI: 10.1509/jppm.27.1.98     Document Type: Review

References (43)

1. Adelstein, Jonathan S. (2005), "Remarks of Jonathan S. Adelstein Commissioner, Federal Communications Commission: A Response to the Commercialization of American Media Before the Media Institute," (May 25), (accessed November 30, 2005), [available at http://hraunfoss.fcc.gov/ edocs_public/attachmatch/DOC-258962Al.doc].
2. Adkinson, Tom (2005), "The Product Placement Game," The City Paper, (May 4), (accessed February 6, 2008), [available at http://www.nashvillecitypaper.com/news.php?viewStory= 41194].
3. Brandweek (2005), Untitled article, (January 17), (accessed November 19, 2005), [available at http://www.insidebrandedentertainment.com/bep/ article_display.jsp?vnu_content_id= 1000760093].
4. Brodie, Mollyanne, Ursula Foehr, Vicky Rideout, Neal Baer, Carolyn Miller, Rebecca Flournoy, and Drew Altman (2001), "Communicating Health Information Through the Entertainment Media," Health Affairs, 20 (1), 192-99.
5. Business Wire (2005), "Court TV Offers the Prescription for Great ROI: The Network Joins Exhibitors at the Pharmaceutical Marketing Congress in Philadelphia September 12-14," (June), (accessed November 19, 2005), [available at http://www.freedomcrowsnest.org/forum/viewtopic.php?t=12341].
6. Edwards, Jim (2005a), "The Tracker: Drug Product Placements Flying Under PDA's Radar," (November), (accessed November 22, 2005), [available at http://web.lexis-nexis.com/universe/document?_m= a702a0afe891cc6430ceb036a7cdfa69&_docnum=1&wchp=dGLbVtb-zSkVb&_md5= c310d2229f2a 93fce0e8d83e82d14d5a].
7. (2005b), "The Tracker: P&G Placements Triple Amid Cutbacks in TV Ad Spending," (June), (accessed November 18, 2005), [available at http://www.insidebrandedentertainment. com/bep/article_display.jsp? vnu_content_id=1000968456].
8. Engle, Mary K., on behalf of the Federal Trade Commission (2005), FTC Letter to Gary Ruskin, (February 10), (accessed November 30, 2006), [available at http://www.commercialalert.org/FTCletter2.10.05.pdf].
9. ERMA (2005), "Message from the President," (accessed November 25, 2005), [available at http://entertainment.howstuffworks.com/framed.htm? parent=product-placement.htm&url=http:// www.erma.org/].
10. FCC (2005), "Payola and Sponsorship Identification," (accessed November 30, 2005), [available at http://64.233.179.104/search?q=cache: w5u089bF1hEJ:www.fcc.gov/eb/broadcast/sponsid.html+fcc+sponsor+disclosure& hl=en&gl-us&ct= clnk&cd=1].
11. FDA (1999), Guidance for Industry: Consumer-Directed Broadcast Advertisements, (accessed November 19, 2005), [available at http://www.fda.gov/cder/guidance/1804fnl.pdf].
12. (2004), "Guidance for Industry: Help-Seeking and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms," (accessed September 10, 2006), [available at http://www.fda.gov/CDER/GUIDANCE/ 6019dft.pdf].
13. (2006), "Leuprolide in Treating Adults with Hypogonadotropism," (accessed April 1, 2006), [available at http://clinicaltrials.gov/ct/show/ NCT00004438].
14. Fontanarosa, Phil, Rennie Drummond, and Catherine DeAngelis (2003), "The Need for Regulation of Dietary Supplements: Lessons from Ephedra," Journal of the American Medical Association, 289 (12), 1568-70.
15. Frank, Richard, Ernest R. Berndt, Julie Donohue, Arnold Donohue, and Meridith Rosenthal (2000), "Trends in Direct-to-Consumer Advertising of Prescription Drugs," Henry J. Kaiser Family Foundation, (February), (accessed November 18, 2005), [available at http://66.102.7.104/search?q=cache: 136ujxbIFqwJ: www.kff.org/rxdrugs/loader.cfm%3Furl%3D/commonspot/security/ getfile.cfm%26PageID%3D14881+IMS+health+competitive+media+reporting&hl= en&ie=UTF-8].
16. Friedman, Wayne (2004), "Placement Bonanza Remains Elusive; Advertisers, Programmers Continue to Test the Waters, but Big Deals and Big Payoffs Are Slow to Materialize," Television Week, (October), (accessed November 25, 2005), [available at http://www.findarticles.com/p/ articles/mi_go2037/is_200410/ai_n6662198].
17. FTC (2002), "Prepared Statement of the Federal Trade Commission, J. Howard Beales III, Director, Bureau of Consumer Protection, Before the Committee on Governmental Affairs Subcommittee on Oversight of Government Management, Restructuring and the District of Columbia United States Senate," (accessed September 1, 2006), [available at http://www.ftc.gov/os/2002/10/ dietary_testimony.htm].
18. (2005), "Frequently Asked Advertising Questions: A Guide for Small Business," (accessed November 24, 2005), [available at http://www.ftc.gov/ bcp/conline/pubs/buspubs/ad-faqs.htm].
19. Gabriel, Mary (2000), "Product Placement Jumps Off Movie Screens," (April 10), (accessed November 19, 2005), [available at http://www.aef.com/industry/news/data/perspective/1206].
20. Gahart, Martin T., Louise M. Duhamel, Anne Dievler, and Roseanne Price (2003), "Examining the PDA's Oversight of Direct-to-Consumer Advertising," Health Affairs Web Exclusive, (February), 120-23, (accessed November 20, 2005), [available at http://content.healthaffairs.org/cgi/reprint/ hlthaff.w3.120v1].
21. Hamilton, David P. (2002), "Celebrities Help 'Educate' Public on New Drugs," The Wall Street Journal, (April 21), B1.
22. The Henry J. Kaiser Family Foundation (2003), "Impact of Direct-to-Consumer Advertising on Prescription Drug Spending," (June), (accessed November 20, 2005), [available at http://www.kff.org/rxdrugs/6084- index.cfm].
23. Holmer, Alan F. (2000), "Direct-to-Consumer Advertising: Strengthening Our Health Care System," New England Journal of Medicine, 346 (7), 526-28.
24. IMS Health (2001), "Integrated Promotional Services, U.S. Pharmaceutical Prescription Market 1996-2000," (March), (accessed November 17, 2005), [available at http://www.imshealth.com/ims/portal/front/articleC/0, 2777,6599_41551570_41718516,00. html].
25. Join Together (2005), "Wedding Disaster: Movie's Alcohol Product Placement Raises Ire," (accessed September 1, 2006), [available at http://www.jointogether.org/news/headlines/inthenews/2005/wedding-disaster- movies-ire.html].
26. Kravitz, Richard, Ronald Epstein, Mitchell Feldman, Carol Franz, Rahman Azari, Michael Wilkes, Ladson Hinton, and Peter Franks (2005), "Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial," Journal of the American Medical Association, 293 (16), 1995-2002.
27. Lyles, Alan (2002), "Direct Marketing of Pharmaceuticals to Consumers," Annual Review of Public Health, 23, 73-91.
28. Mekemson, Curtis and Stanton Glantz (2002), "How the Tobacco Industry Built Its Relationship with Hollywood," Tobacco Control, 11 (March), 81-91.
29. Moore, Frazier (2005), "Product Placements Infiltrate TV Shows," (July 19), (accessed November 24, 2005), [available at http://medialit.med.sc.edu/product_placements_infiltrate_tv.htm].
30. Nielsen Media Research (2005), "U.S. Advertising Spending Rose 5.7% in the First Half of 2005, Nielsen Monitor-Plus Reports," Nielsen news release, (August 30), (accessed November 17, 2005), [available at http://www.nielsenmedia.com/monitor-plus/in_the_news/releases/ M+FirstHalfAdSpend08-30-05.htm].
31. Petersen, Melody (2002a), "CNN to Reveal When Guests Promote Drugs for Companies," The New York Times, (August 23), C1.
32. (20026), "Heartfelt Advice, Hefty Fees," The New York Times, (August 11), C1.
33. Pharmaceutical Executive (2004), "Alternative Media: Drugs on Film," (September 1), (accessed November 17, 2005), [available at http://www.pharmexec.com/pharmexec/content/printContentPopup.jsp?id=123010].
34. PhRMA (2004), "Pharmaceutical Marketing and Promotion Questions and Answers: Tough Questions, Straight Answers," (Fall), (accessed November 18, 2005), [available at http://www.phrma.org/files/Tough_Questions.pdf].
35. Pitts, Peter J. (2004), "Turning Point or Tipping Point: New FDA Draft Guidance and the Future of DTC Advertising," Health Affairs Web Exclusive, 259-261, (accessed November 18, 2005), [available at http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.259v1].
36. PQMedia (2005), "Product Placement Spending in Media 2005: Executive Summary," (March), (accessed November 25, 2005), [available at http://www.pqmedia.com/ppsm2005-es.pdf].
37. Robinson, Andrew R., Kirsten B. Hohmann, Julie I. Rifkin, Daniel Topp, Christine M. Gilroy, Jeffrey A. Pickard, and Robert J. Anderson (2004), "Direct-to-Consumer Pharmaceutical Advertising: Physician and Public Opinion and Potential Effects on the Physician-Patient Relationship," Archives of Internal Medicine, 164 (4), 427-32.
38. Russell, Cristel A. (2002), "Investigating the Effectiveness of Product Placements in Television Shows: The Role of Modality and Plot Connection Congruence on Brand Memory and Attitude," Journal of Consumer Research, 29 (3), 306-318.
39. and Barbara Stern (2006), "Consumers, Characters, and Products," Journal of Advertising, 35 (1), 7-12.
40. Sargent, James, Jennifer Tickle, Michael Beach, Madeline Dalton, Bridget Ahrens, and Todd Heatherton (2001), "Brand Appearances in Contemporary Cinema Films and Contribution to Global Marketing of Cigarettes," The Lancet, 357 (9249), 29-32.
41. Vista Group (2005), "Why Vista Group Product Placement?" (accessed November 24, 2005), [available at http://www.vistagroupusa.com/serv02. htm].
42. Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz (2000), "Direct-to-Consumer Prescription Drug Advertising: Trends, Impact and Implications," Health Affairs, 19 (2), 110-28.
43. Woloshin, Steve, Lisa M. Schwarte, Jennifer Tremmel, and H. Gilbert Welch (2001), "Direct-to-Consumer Advertisements for Prescription Drugs: What Are Americans Being Sold?" The Lancet, 358 (9288), 1141-46.